-
Agut H, Bonnafous P, Gautheretdejean A. 2015. Laboratory and clinical aspects of human herpesvirus 6 infections. Clin Microbiol Rev, 28: 313–335.
doi: 10.1128/CMR.00122-14
-
Ahmed W, Philip PS, Attoub S, Khan G. 2015. Epstein-Barr virus infected cells release Fas-ligand in exosomal fractions and induce apoptosis in recipient cells via the extrinsic pathway. J Gen Virol, 96: 3646–3659.
doi: 10.1099/jgv.0.000313
-
Akers JC, Gonda D, Kim R, Carter BS, Chen CC. 2013. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol, 113: 1–11.
doi: 10.1007/s11060-013-1084-8
-
Akinyi B, Odhiambo C, Otieno F, Inzaule S, Oswago S, Kerubo E, Ndivo R, Zeh C. 2017. Prevalence, incidence and correlates of HSV-2 infection in an HIV incidence adolescent and adult cohort study in western Kenya. PloS One, 12: e0178907.
doi: 10.1371/journal.pone.0178907
-
Anderson MR, Kashanchi F, Jacobson S. 2016. Exosomes in Viral Disease. Neurotherapeutics, 13: 535–546.
doi: 10.1007/s13311-016-0450-6
-
Arnold N, Messaoudi I. 2017. Simian varicella virus causes robust transcriptional changes in T cells that support viral replication. Virus Res, 238:226.
doi: 10.1016/j.virusres.2017.07.004
-
Baglio SR, van Eijndhoven MA, Koppers-Lalic D, Berenguer J, Lougheed SM, Gibbs S, Léveillé N, Rinkel RN, Hopmans ES, Swaminathan S. 2016. Sensing of latent EBV infection through exosomal transfer of 5’pppRNA. Proc Natl Acad Sci U S A, 113: E587–E596.
doi: 10.1073/pnas.1518130113
-
Calistri A, Sette P, Salata C, Cancellotti E, Forghieri C, Comin A, Göttlinger H, Campadellifiume G, Palù G, Parolin C. 2007. Intracellular Trafficking and Maturation of Herpes Simplex Virus Type 1 gB and Virus Egress Require Functional Biogenesis of Multivesicular Bodies. J Virol, 81: 11468–11478.
doi: 10.1128/JVI.01364-07
-
Cepeda V, Esteban M, Fraileramos A. 2010. Human cytomegalovirus final envelopment on membranes containing both trans-Golgi network and endosomal markers. Cell Microbiol, 12: 386–404.
doi: 10.1111/cmi.2010.12.issue-3
-
Chan T, Barra NG, Lee AJ, Ashkar AA. 2011. Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa. J Reprod Immunol, 88: 210–218.
doi: 10.1016/j.jri.2011.01.001
-
Choi UY, Park A, Jung JU. 2017. Double the Trouble When Herpesviruses Join Hands. Cell Host Microbe, 22: 5–7.
doi: 10.1016/j.chom.2017.06.016
-
Chugh PE, Sin SH, Ozgur S, Henry DH, Menezes P, Griffith J, Eron JJ, Damania B, Dittmer DP. 2013. Systemically Circulating Viral and Tumor-Derived MicroRNAs in KSHV-Associated Malignancies. PloS Pathog, 9: e1003484.
doi: 10.1371/journal.ppat.1003484
-
Crump CM, Yates C, Minson T. 2007. Herpes Simplex Virus Type 1 Cytoplasmic Envelopment Requires Functional Vps4. J Virol, 81: 7380–7387.
doi: 10.1128/JVI.00222-07
-
Ding L, Li L, Yang J, Zhou S, Li W, Tang M, Shi Y, Yi W, Cao Y. 2010. Latent membrane protein 1 encoded by Epstein-Barr virus induces telomerase activity via p16INK4A/Rb/E2F1 and JNK signaling pathways. J Med Virol, 79: 1153–1163.
-
Dolcetti R. 2015. Cross-talk between Epstein-Barr virus and microenvironment in the pathogenesis of lymphomas. Semin Cancer Biol, 34: 58–69.
doi: 10.1016/j.semcancer.2015.04.006
-
Dreyfus DH. 2013. Herpesviruses and the microbiome. J Allergy Clin Immunol, 132: 1278–1286.
doi: 10.1016/j.jaci.2013.02.039
-
Duijvesz D, Luider T, Bangma CH, Jenster G. 2011. Exosomes as biomarker treasure chests for prostate cancer. Eur Urol, 59: 823–831.
doi: 10.1016/j.eururo.2010.12.031
-
Fraile-Ramos A, Pelchen-Matthews A, Risco C, Rejas MT, Emery VC, Hassan-Walker AF, Esteban M, Marsh M. 2007. The ESCRT machinery is not required for human cytomegalovirus envelopment. Cell Microbiol, 9: 2955–2967.
doi: 10.1111/j.1462-5822.2007.01024.x
-
Gallo A, Vella S, Miele M, Timoneri F, Di BM, Bosi S, Sciveres M, Conaldi PG. 2016. Global profiling of viral and cellular non-coding RNAs in Epstein-Barr virus-induced lymphoblastoid cell lines and released exosome cargos. Cancer Lett, 388: 334–343.
-
Han Z, Liu X, Chen X, Zhou X, Du T, Roizman B, Zhou G. 2016. miR-H28 and miR-H29 expressed late in productive infection are exported and restrict HSV-1 replication and spread in recipient cells. Proc Natl Acad Sci U S A, 113: E894-E901.
doi: 10.1073/pnas.1525674113
-
Hancock MH, Skalsky RL. 2017. Roles of Non-coding RNAs During Herpesvirus Infection. DOI: 10.1007/82_2017_31.
-
Hogue IB, Scherer J, Enquist LW. 2016. Exocytosis of Alphaherpesvirus Virions, Light Particles, and Glycoproteins Uses Constitutive Secretory Mechanisms. Mbio, 7: e00820–e00816.
-
Hudson AW. 2014. Roseoloviruses and their modulation of host defenses. Curr Opin Virol, 9: 178–187.
doi: 10.1016/j.coviro.2014.09.009
-
Hurley JH. 2015. ESCRTs are everywhere. EMBO J, 34: 2398–2407.
doi: 10.15252/embj.201592484
-
Hurwitz SN, Nkosi D, Conlon MM, York SB, Liu X, Tremblay DC, Meckes DG Jr. 2016. CD63 regulates Epstein-Barr virus LMP1 exosomal packaging, enhancement of vesicle production, and non-canonical NF-κB signaling. J Virol, 91. pii: e02251-16.
-
Iwakiri D. 2015. Multifunctional non-coding Epstein-Barr virus encoded RNAs (EBERs) contribute to viral pathogenesis. Virus Res, 212: 30–38.
-
Jia S, Zhai H, Zhao M. 2014. MicroRNAs regulate immune system via multiple targets. Discov Med, 18: 237–247.
-
Meckes DG Jr. 2015. Exosomal Communication Goes Viral. J Virol, 89: 5200–5203.
doi: 10.1128/JVI.02470-14
-
Meckes DG Jr, Gunawardena HP, Dekroon RM, Heaton PR, Edwards RH, Ozgur S, Griffith JD, Damania B, Raab-Traub N. 2013. Modulation of B-cell exosome proteins by gamma herpesvirus infection. Proc Natl Acad Sci U S A, 110: 2925–2933.
doi: 10.1073/pnas.1303906110
-
Kalamvoki M, Deschamps T. 2016. Extracellular vesicles during Herpes Simplex Virus type 1 infection: an inquire. Virol J, 13: 1–12.
doi: 10.1186/s12985-015-0456-4
-
Kalamvoki M, Du T, Roizman B. 2014. Cells infected with herpes simplex virus 1 export to uninfected cells exosomes containing STING, viral mRNAs, and microRNAs. Proc Natl Acad Sci U S A, 111: E4991–E4996.
doi: 10.1073/pnas.1419338111
-
Knipe DM, Raja P, Lee J. 2017. Viral gene products actively promote latent infection by epigenetic silencing mechanisms. Curr Opin Infect Dis, 23: 68–74.
-
Kurapati S, Sadaoka T, Rajbhandari L, Jagdish B, Shukla P, Kim YJ, Lee G, Cohen JI, Venkatesan A. 2017. Role of JNK pathway in varicella-zoster virus lytic infection and reactivation. J Virol. pii: e00640-17.
-
Lee AJ, Ashkar AA. 2012. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development. Curr Opin Infect Dis, 25: 92–99.
doi: 10.1097/QCO.0b013e32834e9a56
-
Lee Y, El AS, Wood MJ. 2012. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet, 21: 125–134.
doi: 10.1093/hmg/dds317
-
Li L, Chen XP, Li YJ. 2010. MicroRNA-146a and human disease. Scand J Immunol, 71: 227–231.
doi: 10.1111/sji.2010.71.issue-4
-
Li L, Li Z, Zhou S, Xiao L, Guo L, Tao Y, Tang M, Shi Y, Li W, Yi W. 2007. Ubiquitination of MDM2 modulated by Epstein-Barr virus encoded latent membrane protein 1. Virus Res, 130: 275–280.
doi: 10.1016/j.virusres.2007.05.013
-
Lin Z, Swan K, Zhang X, Cao S, Brett Z, Drury S, Strong MJ, Fewell C, Puetter A, Wang X. 2016. Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells. J Virol, 90: 3469–3479.
doi: 10.1128/JVI.02830-15
-
Lo AKF, Dawson CW, Young LS, Lo KW. 2017. The role of Metabolic Reprogramming in γ-Herpesvirus-associated Oncogenesis. Int J Cancer. 141: 1512–1521.
doi: 10.1002/ijc.v141.8
-
Miettinen JJ, Matikainen S, Nyman TA. 2012. Global Secretome Characterization of Herpes Simplex Virus 1-Infected Human Primary Macrophages. J Virol, 86: 12770–12778.
doi: 10.1128/JVI.01545-12
-
Mori Y, Koike M, Moriishi E, Kawabata A, Tang H, Oyaizu H, Uchiyama Y, Yamanishi K. 2008. Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic, 9: 1728–1742.
doi: 10.1111/tra.2008.9.issue-10
-
Olsson J, Kok E, Adolfsson R, Lövheim H, Elgh F. 2017. Herpes virus seroepidemiology in the adult Swedish population. Immun Ageing, 14: 10.
doi: 10.1186/s12979-017-0093-4
-
Ota M, Serada S, Naka T, Mori Y. 2014. MHC class I molecules are incorporated into human herpesvirus-6 viral particles and released into the extracellular environment. Microbiol Immunol, 58: 119–125.
doi: 10.1111/1348-0421.12121
-
Parra M, Alcala A, Amoros C, Baeza A, Galiana A, Tarragó D, García-Quesada MÁ, Sánchez-Hellín V. 2017. Encephalitis associated with human herpesvirus-7 infection in an immunocompetent adult. Virol J, 14: 97.
doi: 10.1186/s12985-017-0764-y
-
Pawliczek T, Crump CM. 2009. Herpes Simplex Virus Type 1 Production Requires a Functional ESCRT-III Complex but Is Independent of TSG101 and ALIX Expression. J Virol, 83: 11254–11264.
doi: 10.1128/JVI.00574-09
-
Pegtel DM. 2013. Oncogenic herpesviruses sending mixed signals. Proc Natl Acad Sci U S A, 110: 12503–12504.
doi: 10.1073/pnas.1310928110
-
Purushothaman P, Dabral P, Gupta N, Sarkar R, Verma SC. 2016. KSHV Genome Replication and Maintenance. Front Microbiol, 7: 54.
-
Riva N, Franconi I, Meschiari M, Franceschini E, Puzzolante C, Cuomo G, Bianchi A, Cavalleri F, Genovese M, Mussini C. 2017. Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature. Infection, 45: 1–4.
-
Sotelo JR, Porter KR. 1959. An Electron Microscope Study of the Rat Ovum. J Biophys Biochem Cytol, 5: 327–342.
doi: 10.1083/jcb.5.2.327
-
Sullivan BM, Coscoy L. 2010. The U24 protein from human herpesvirus 6 and 7 affects endocytic recycling. J Virol, 84: 1265–1275.
doi: 10.1128/JVI.01775-09
-
Szatanek R, Bajkrzyworzeka M, Zimoch J, Lekka M, Siedlar M, Baran J. 2017. The Methods of Choice for Extracellular Vesicles (EVs) Characterization. Int J Mol Sci, 18.pii: E1153.
-
Tandon R, Aucoin DP, Mocarski ES. 2009. Human Cytomegalovirus Exploits ESCRT Machinery in the Process of Virion Maturation. J Virol, 83: 10797–10807.
doi: 10.1128/JVI.01093-09
-
Temme S, Eis-Hübinger AM, Mclellan AD, Koch N. 2010. The herpes simplex virus-1 encoded glycoprotein B diverts HLA-DR into the exosome pathway. J Immunol, 184: 236–243.
doi: 10.4049/jimmunol.0902192
-
Thakker S, Verma SC. 2016. Co-infections and Pathogenesis of KSHV-Associated Malignancies. Front Microbiol, 7: 151.
-
Tkach M, Théry C. 2016. Communication by Extracellular Vesicles: Where We Are and Where We Need to Go. Cell, 164: 1226.
doi: 10.1016/j.cell.2016.01.043
-
van Diemen FR, Lebbink RJ. 2016. CRISPR/Cas9, a powerful tool to target human herpesviruses. Cellular Microbiology. DOI: 10.1111/cmi.12694.
-
Veettil MV, Bandyopadhyay C, Dutta D, Chandran B. 2014. Interaction of KSHV with host cell surface receptors and cell entry. Viruses, 6: 4024–4046.
doi: 10.3390/v6104024
-
Walker JD, Maier CL, Pober JS. 2009. Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes. J Immunol, 182: 1548–1559.
doi: 10.4049/jimmunol.182.3.1548
-
Wang J, Sun X, Zhao J, Yang Y, Cai X, Xu J, Cao P. 2017. Exosomes: A Novel Strategy for Treatment and Prevention of Diseases. Front Pharmacol, 8: 300.
doi: 10.3389/fphar.2017.00300
-
Yoon C, Kim J, Park G, Kim S, Kim D, Hur DY, Kim B, Kim YS. 2016. Delivery of miR-155 to retinal pigment epithelial cells mediated by Burkitt’s lymphoma exosomes. Tumor Biol, 37: 313–321.
doi: 10.1007/s13277-015-3769-4
-
Zhang J, Zhu L, Lu X, Feldman ER, Keyes LR, Wang Y, Fan H, Feng H, Xia Z, Sun J. 2015a. Recombinant Murine Gamma Herpesvirus 68 Carrying KSHV G Protein-Coupled Receptor Induces Angiogenic Lesions in Mice. PloS Pathog, 11: e1005001.
doi: 10.1371/journal.ppat.1005001
-
Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W. 2015b. Exosomes in cancer: small particle, big player. J Hematol Oncol, 8: 83.
doi: 10.1186/s13045-015-0181-x
-
Zheng H, Li L, Hu D, Deng X, Cao Y. 2007. Role of Epstein-Barr Virus Encoded Latent Membrane Protein 1 in the Carcinogenesis of Nasopharyngeal Carcinoma. Cell Mol Immunol, 4: 185–196.
-
Zheng Y, Zhang W, Ye Q, Zhou Y, Xiong W, He W, Deng M, Zhou M, Guo X, Chen P. 2012. Inhibition of Epstein-Barr Virus Infection by Lactoferrin. J Innate Immun, 4: 387–398.
doi: 10.1159/000336178
-
Zhu Y, Yan Y, Guo J, Ying D, Ye L, Qiu J, Zeng Z, Wu X, Xing Y, Xiang L. 2017. Ex vivo2D and 3D HSV-2 infection model using human normal vaginal epithelial cells. Oncotarget, 8: 15267–15282.
-
Zuo L, Yu H, Liu L, Tang Y, Wu H, Jing Y, Zhu M, Du S, Lian Z, Li C. 2015. The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB. Oncotarget, 6: 41033–41044.
doi: 10.18632/oncotarget.v6i38
-
Zuo L, Yue W, Du S, Xin S, Zhang J, Liu L, Li G, Lu J. 2017. An update: Epstein-Barr virus and immune evasion via microRNA regulation. Virol Sin, 32: 175–187.
doi: 10.1007/s12250-017-3996-5